Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Kingston Political Update.
Press releases published on August 4, 2025
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Centene Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – CNC
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Centene Corporation (NYSE: CNC) between December 12, 2024 and June 30, 2025, both dates inclusive (the “Class Period”), …
Sable Offshore Corp. (SOC) Hit with Lawsuit Over Alleged Misleading Statements on California Oil Restart – Hagens Berman
SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Sable Offshore Corp. (NYSE: SOC) is now at the center of a securities class-action lawsuit, alleging that the company misled investors to inflate its stock price just before a major secondary offering. The …
ROSEN, LEADING INVESTOR COUNSEL, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ANRO
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Alto Neuroscience, Inc. (NYSE: ANRO): (i) pursuant and/or traceable to Alto’s initial public offering conducted on or …
Lockheed Martin (LMT) Faces Investor Scrutiny Over Company’s Disclosures About Aeronautics and RMS Segments’ Performance, Securities Class Action Pending -- Hagens Berman
SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit styled Khan v. Lockheed Martin Corporation, et al., No. 1:25-cv-06197 (S.D.N.Y.) has been filed and seeks to represent investors who purchased or otherwise acquired Lockheed …
Replimune (REPL) Faces Securities Class Action Following Stock’s Collapse Amid FDA’s Rejection of Melanoma Drug - Hagens Berman
SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit, styled Jboor v. Replimune Group, Inc., et al., No. 1:25-cv-12085 (D. Mass.), has been filed and seeks to represent investors who purchased or otherwise acquired Replimune ( …
Centene Corporation (CNC) Shares Fall ~10% Pre-Market After Reporting Q2 2025 Diluted Loss Per Share, Class Action Lawsuit Over “Inflated Guidance” Pending – Hagens Berman
SAN FRANCISCO , Aug. 04, 2025 (GLOBE NEWSWIRE) -- Before the markets opened on July 25, 2025, investors in Centene Corporation (NYSE: CNC) saw the price of their shares decline about 10% in pre-market trading after the company reported disastrous Q2 2025 …
Berger Montague PC Investigating Claims on Behalf of Novo Nordisk A/S (NYSE: NVO) After Class Action Filing
PHILADELPHIA, Aug. 04, 2025 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces a class action lawsuit against Novo Nordisk A/S (NYSE: NVO) (“Novo” or the “Company”) on behalf of investors who purchased or otherwise acquired …
Sarepta Therapeutics (SRPT) Announces Restructuring and ELEVIDYS Black Box Warning, EMA Recommends Refusal of Marketing Authorization, Securities Class Action Pending – Hagens Berman
SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- On July 16, 2025, Sarepta Therapeutics (NASDAQ: SRPT) announced a major restructuring that involves, in part, a 36% workforce reduction (500 employees) and other steps to annually save about $400 million. …
Hims & Hers Health, Inc. (HIMS) - Lawmakers Urge Crackdown On Illegal Weight Loss Drugs, Novo’s Termination of Collaboration With HIMS Triggers Securities Class Actions -- Hagens Berman
SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- This latest development follows an announcement by Novo Nordisk on June 23, 2025, the Danish maker of the FDA-approved weight-loss medication Wegovy® (a GLP-1 treatment for obesity), that it terminated its …
CLASS ACTION NOTICE: Berger Montague Advises Fiserv, Inc. (NYSE: FI) Investors to Inquire About a Securities Fraud Class Action
PHILADELPHIA, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC is investigating claims under the federal securities laws against Fiserv, Inc. (NYSE: FI) (“Fiserv” or the “Company”), a financial technology and payment solutions provider headquartered in …